RA Medical Systems (NYSE:RMED) will be announcing its earnings results after the market closes on Tuesday, November 13th. Analysts expect the company to announce earnings of ($0.36) per share for the quarter.

RMED stock opened at $8.91 on Friday. RA Medical Systems has a 1 year low of $8.29 and a 1 year high of $22.00.

A number of brokerages have recently commented on RMED. SunTrust Banks began coverage on RA Medical Systems in a report on Monday, October 22nd. They set a “buy” rating and a $16.00 price target on the stock. Cantor Fitzgerald began coverage on RA Medical Systems in a report on Monday, October 22nd. They set an “overweight” rating and a $21.00 price target on the stock. Piper Jaffray Companies began coverage on RA Medical Systems in a report on Monday, October 22nd. They set an “overweight” rating and a $23.00 price target on the stock. Finally, Maxim Group began coverage on RA Medical Systems in a report on Friday, November 2nd. They set a “buy” rating and a $23.00 price target on the stock.

COPYRIGHT VIOLATION WARNING: “RA Medical Systems (RMED) Scheduled to Post Quarterly Earnings on Tuesday” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://theolympiareport.com/2018/11/11/ra-medical-systems-rmed-scheduled-to-post-quarterly-earnings-on-tuesday.html.

RA Medical Systems Company Profile

Ra Medical Systems, Inc, a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.

Featured Article: Using the New Google Finance Tool

Receive News & Ratings for RA Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RA Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.